Enveric Biosciences, Inc.
ENVB
$1.69
$0.095.63%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.63M | -2.19M | -1.87M | -2.52M | -2.19M |
| Total Depreciation and Amortization | 37.20K | 39.50K | 40.40K | 40.00K | 81.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 108.30K | 269.70K | 58.30K | 206.30K | 191.30K |
| Change in Net Operating Assets | -768.90K | 100.10K | -300.00K | 382.80K | -478.90K |
| Cash from Operations | -2.26M | -1.78M | -2.08M | -1.89M | -2.39M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.50M | 2.69M | 2.99M | 449.10K | 4.45M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2.50M | 2.69M | 2.99M | 449.10K | 4.45M |
| Foreign Exchange rate Adjustments | -15.10K | 15.60K | -9.60K | -3.60K | -3.90K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 231.30K | 919.90K | 907.80K | -1.44M | 2.05M |